---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-001281"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2023-01-19T23:59:59+00:00"
generated_at: "2026-06-20T13:45:02.985898+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CFO John P. Hamill resigns; John Tattory appointed interim CFO effective Jan 27, 2023

## Summary
- John P. Hamill resigns as CFO effective Jan 27, 2023 for personal reasons; no disagreement with company.
- John Tattory appointed Interim CFO effective Jan 27, 2023; will serve as principal financial and accounting officer.
- Tattory previously served as Windtree CFO from 2014 to 2020; will consult via LifeSci Associates at hourly rate.
- Company to commence search for a permanent CFO.

## SEC filing metadata
- accession: 0001437749-23-001281
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2023-01-19T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774923001281/0001437749-23-001281-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774923001281/wint20230118_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-001281
- JSON: https://secwatch.observer/filing/0001437749-23-001281.json
- Plain text: https://secwatch.observer/filing/0001437749-23-001281.txt

## Key facts
- Executive change
  John P. Hamill resigned as Senior Vice President, Chief Financial Officer and Corporate Secretary at WINDTREE THERAPEUTICS INC /DE/.
  - Action: resigned
  - Role: Senior Vice President, Chief Financial Officer and Corporate Secretary
  source text: On January 17, 2023, John P. Hamill, the Senior Vice President, Chief Financial Officer and Corporate Secretary of Windtree Therapeutics, Inc. (the “Company”) notified the Company of his decision to resign effective as of January 27, 2023 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774923001281/0001437749-23-001281-index.htm
- Executive change
  John Tattory was appointed as Interim Chief Financial Officer at WINDTREE THERAPEUTICS INC /DE/.
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: On January 18, 2023, the board of directors of the Company appointed John Tattory as Interim Chief Financial Officer, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774923001281/0001437749-23-001281-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.